Changes in co-prescribing antipsycotics in patients with dementia treated with cholinesterase inhibitors
✍ Scribed by Nobili, Alessandro; Franchi, Carlotta; Pasina, Luca; De Vittorio, Luigi; Tettamanti, Mauro; Garrì, Mariateresa; Lucca, Ugo; Riva, Emma; Recchia, Angela; Fortino, Ida; Bortolotti, Angela; Merlino, Luca
- Book ID
- 121958551
- Publisher
- Elsevier Science
- Year
- 2011
- Tongue
- English
- Weight
- 127 KB
- Volume
- 7
- Category
- Article
- ISSN
- 1552-5260
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## Background Individuals who have Mild Cognitive Impairment (MCI) may be in a transitional stage between aging and Alzheimer's disease (AD). The high rate of conversion from MCI to AD makes early treatment an important clinical issue. Recent evidence suggests that cognitive training i
## Abstract ## Objective To compare efficacy of different cholinesterase inhibitors (ChEIs) for treating patients with dementia with Lewy bodies (DLB). ## Design Retrospective comparison of three independent clinical studies of ChEI treatment using donepezil, galantamine or rivastigmine in patie